Filter Results:
(3,192)
Show Results For
- All HBS Web
(3,192)
- People (7)
- News (428)
- Research (2,367)
- Events (1)
- Multimedia (5)
- Faculty Publications (1,948)
Show Results For
- All HBS Web
(3,192)
- People (7)
- News (428)
- Research (2,367)
- Events (1)
- Multimedia (5)
- Faculty Publications (1,948)
- August 1995 (Revised June 1997)
- Case
Hillcrest Research Associates, Inc.
Hillcrest designs and administers testing procedures for drugs to determine whether they pass FDA specifications. As the company grows, it encounters problems with information technology and with the clinical research associates, who feel pressured to report more... View Details
Keywords: Growth Management; Information Technology; Health Testing and Trials; Pharmaceutical Industry
Barnes, Louis B. "Hillcrest Research Associates, Inc." Harvard Business School Case 496-021, August 1995. (Revised June 1997.)
- 10 Aug 2020
- Research & Ideas
COVID's Surprising Toll on Careers of Women Scientists
Foundation. About the Author Rachel Layne is a writer based in the Boston area. [Image: valentinrussanov] Related Reading Restaurant Revolution: How the Industry Is Fighting to Stay Alive Who Guarantees Your Workplace Is Safe for Return?... View Details
- 21 Jan 2014
- First Look
First Look: January 21
several mechanisms: by conferring employer recognition, by enhancing social visibility, and by facilitating social comparison. In a nationwide health worker training program in Zambia, we design a field experiment to unbundle these... View Details
Keywords: Sean Silverthorne
- 01 Mar 2016
- News
Alumni and Faculty Books for March 2016
private profit not come at the expense of consumer welfare. This book assembles 17 case studies at the intersection of business and public health to illustrate how each side can inform and benefit the other. Through contemporary examples... View Details
- September 2008 (Revised March 2020)
- Supplement
Medtronic: Patient Management Initiative (B)
The (B) case provides the denouement to the (A) case about Medtronic's introduction of the Chronicle and remote monitoring business. View Details
Keywords: Health Care and Treatment; Measurement and Metrics; Information Technology; Competitive Strategy; Medical Devices and Supplies Industry
Herzlinger, Regina E. "Medtronic: Patient Management Initiative (B)." Harvard Business School Supplement 309-064, September 2008. (Revised March 2020.)
- 01 Sep 2014
- News
Alumni Achievement Awards 2014
on the next big thing, Dahod marries technological understanding with management expertise to solve high-tech problems and build cutting-edge companies. With five advanced degrees and five successful startups under his belt, Dahod channels his energy into transforming... View Details
- Profile
Craig Baker
built-to-order, high-capacity machines,” Craig says. “The management team I was part of took the company from financial trouble to financial health and growth.” The experience reawakened a possibility he mulled over while in college. “An... View Details
- August 2007 (Revised November 2008)
- Case
Biocon: Launching a New Cancer Drug in India
By: Sunil Gupta and Das Narayandas
Kiran Majumdar-Shaw, the CEO of Biocon has to make product launch timing, pricing, channel, and communications mix decisions relating to the launch of BioMAb, a new cancer drug in India. View Details
Keywords: Price; Health Care and Treatment; Marketing Strategy; Product Launch; Planning; Biotechnology Industry; Biotechnology Industry; India
Gupta, Sunil, and Das Narayandas. "Biocon: Launching a New Cancer Drug in India." Harvard Business School Case 508-026, August 2007. (Revised November 2008.)
- June 2005
- Article
A Rising Drug Industry: Pharmaceuticals since 1870
By: Arthur A. Daemmrich
Daemmrich, Arthur A. "A Rising Drug Industry: Pharmaceuticals since 1870." Chemical and Engineering News (June 2005), 28–42.
- 17 Jan 2012
- First Look
First Look: January 17
reference points or anchors to simplify the complex tasks of valuation and negotiation. Read the paper: http://people.hbs.edu/mbaker/cv/papers/refpt.pdf The Four Habits of High-Value Health Care Organizations Author:Richard M.J. Bohmer... View Details
Keywords: Sean Silverthorne
- April 1998
- Case
Cephalon, Inc.
By: Peter Tufano
In early 1997, Cephalon, awaited an FDA panel's decision on whether its drug, Myotrophin, would be approved. If the drug was approved, the firm might need substantial additional funds to commercialize as well as to buy back rights to it (which had been sold earlier to... View Details
Keywords: Risk Management; Financing and Loans; Health Care and Treatment; Pharmaceutical Industry; United States
Tufano, Peter, Geoffrey Verter, and Markus Mullarkey. "Cephalon, Inc." Harvard Business School Case 298-116, April 1998.
- 15 Jun 2021
- News
Alumni Work to Reverse Bias Through Philanthropy
communities of color who include the voices of community members in their decision-making.” Unknown to Big Funders The NCF focuses on four pillars of underfunded structural challenges: policing and criminal justice reform; economic empowerment; View Details
Keywords: Deborah Blagg
- March 2012
- Article
A 2-phase Labeling and Choice Architecture Intervention to Improve Healthy Food and Beverage Choices
By: Anne Thorndike, Lilian Sonnenberg, Jason Riis, Susan Barraclough and Douglas E. Levy
Objectives: We assessed whether a 2-phase labeling and choice architecture intervention increased sales of healthy food and beverages in a large hospital cafeteria. Methods: Phase 1 was a 3-month color-coded labeling intervention (red="unhealthy" yellow="less healthy"... View Details
Thorndike, Anne, Lilian Sonnenberg, Jason Riis, Susan Barraclough, and Douglas E. Levy. "A 2-phase Labeling and Choice Architecture Intervention to Improve Healthy Food and Beverage Choices." American Journal of Public Health 102, no. 3 (March 2012): 527–533.
- 22 Jul 2021
- News
Mentoring Fashion Startups in Singapore; Rising Star Accolades for Mid-Career Women
the textile industry brings wealth to the local economies. I appreciate the opportunity to introduce technologies and new businesses to these markets so they will be able to adopt sustainable practices.” In addition to Mansukhani and... View Details
Keywords: Margie Kelley
- Web
Blog | Social Enterprise | Harvard Business School
Internship in Global Health Kaleigh Killoran 30 Jul 2019 Before HBS, I moved to Kenya so that I could work on critical infrastructure projects and help bu... Life After Rikers: HBS Alumni Volunteers Complete Project Aimed at Reducing... View Details
- Web
Career Journey | MBA
88% Class of 2024 who actively sought and accepted full-time roles after graduation. Industry Consulting 18% Consumer Products 3% Entertainment / Media 3% Financial Services 39% Health Care 6% Manufacturing... View Details
- April 1991 (Revised November 1997)
- Case
Levi Strauss & Co. and the AIDS Crisis
Keywords: Health Disorders; Employee Relationship Management; Corporate Social Responsibility and Impact; Apparel and Accessories Industry
Tedlow, Richard S. "Levi Strauss & Co. and the AIDS Crisis." Harvard Business School Case 391-198, April 1991. (Revised November 1997.)
- 18 Jul 2018
- Research & Ideas
No More General Tso's? A Threat to 'Knowledge Recombination'
blocked from more traditional work, opened restaurants. But they had to cater to the American palate by adding sweetness to their dishes and combining Chinese and American ingredients into innovations like chop suey and the aforementioned General Tso’s. The American... View Details
- August 2024
- Article
How Do Copayment Coupons Affect Branded Drug Prices and Quantities Purchased?
By: Leemore S. Dafny, Kate Ho and Edward Kong
Drug copayment coupons to reduce patient cost-sharing have become nearly ubiquitous for high-priced brand-name prescription drugs. Medicare bans such coupons on the grounds that they are kickbacks that induce utilization, but they are commonly used by... View Details
Keywords: Prescription Drugs; Coupons; Impact; Health Care and Treatment; Markets; Price; Spending; Pharmaceutical Industry; United States
Dafny, Leemore S., Kate Ho, and Edward Kong. "How Do Copayment Coupons Affect Branded Drug Prices and Quantities Purchased?" American Economic Journal: Economic Policy 16, no. 3 (August 2024): 314–346.
- April 2017
- Supplement
Imprimis (B)
By: Ramon Casadesus-Masanell, Karen Elterman and Marc Appel
This case is a supplement to Imprimis (A). It describes the company’s decision to enter into the pharmaceutical compounding business in 2013–2014. Imprimis purchased a compounded ophthalmological medication called Dropless Therapy, which was injected into patients’... View Details
Keywords: Healthcare; Drug Compounding; Drug Development; Pharmaceuticals; Small Business; Decision-making, Business Model; Mark Baum; Imprimis; Decision Making; Strategy; Health Care and Treatment; Policy; Pharmaceutical Industry; United States
Casadesus-Masanell, Ramon, Karen Elterman, and Marc Appel. "Imprimis (B)." Harvard Business School Supplement 717-496, April 2017.